CS Cancer Solutions - Structured Oncology Intelligence

Ohio Cancer Research Ecosystem | Collaborative Trial Networks & Big Data

Ohio Research Ecosystem

Ohio Cancer Research — Collaborative Trial Networks & Big Data

Understanding oncology research within Ohio's collaborative research ecosystem, including its two NCI-designated comprehensive cancer centers

Purpose & Educational Context

This page provides an educational overview of oncology research in Ohio, with emphasis on the state's collaborative research infrastructure and its two NCI-designated comprehensive cancer centers.

This page does not provide medical advice, treatment recommendations, care navigation, or referral services.

2
NCI-Designated Centers
Big Data
Research Focus
Leading
Hematology
Collaborative
Trial Networks

Population & Regional Context

Ohio's oncology research ecosystem emphasizes collaborative trial networks, hematologic malignancy research, genomic medicine, and data-driven oncology across multiple academic institutions.

NCI-Designated Cancer Centers

Ohio's two comprehensive cancer research institutions

Case Comprehensive Cancer Center

NCI-Designated Comprehensive Cancer Center

Case Comprehensive Cancer Center at Case Western Reserve University is one of Ohio's two NCI-designated comprehensive cancer centers and serves as a central hub for collaborative trial networks and hematologic oncology research.

Research Focus

  • •NCI-designated comprehensive cancer center
  • •Collaborative clinical trial networks
  • •Hematologic oncology research
  • •Data-driven oncology research infrastructure

Research Contribution

Case CCC supports Ohio's oncology research ecosystem through collaborative trial networks and hematologic malignancy research.

Visit Website
Ohio State University Comprehensive Cancer Center

NCI-Designated Comprehensive Cancer Center (James Cancer Hospital)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital is Ohio's second NCI-designated comprehensive cancer center and serves as a central hub for genomic medicine and data-intensive oncology research.

Research Focus

  • •NCI-designated comprehensive cancer center
  • •Genomic medicine research
  • •Data science and oncology research infrastructure
  • •Large-scale clinical trial coordination

Research Contribution

OSU Comprehensive Cancer Center supports Ohio's precision oncology research ecosystem through genomic medicine and data science initiatives.

Visit Website

Stay Informed About Ohio Cancer Research

Get updates on Ohio-based oncology research and clinical trials.

We respect your privacy. No medical information required.

Explore More Research Resources

Access research context across U.S. states and globally

Latest Research Ecosystem Developments

Ohio — Ohio's cancer research ecosystem is experiencing significant growth through new institutional centers, state-funded pediatric initiatives, and expanded clinical trial infrastructure.

Updated October 16, 2026

Launch of the Northwest Ohio Cancer Research Institute

The University of Toledo established this new institute in December 2025 to centralize expertise, accelerate the translation of laboratory discoveries into patient care, and provide infrastructure for large-scale grant competition.

University of Toledo

$5 Million State Investment in Pediatric Cancer Research

Governor Mike DeWine announced a $5 million statewide funding initiative in December 2025 to support pediatric cancer studies at major institutions, including Cincinnati Children’s Hospital and Nationwide Children’s Hospital, focusing on less invasive diagnostic testing.

Office of the Governor of Ohio

NCI Grant Awarded for AML Treatment Resistance Study

The OSUCCC – James received a $3.46 million grant from the National Cancer Institute in 2026 to investigate why older adults with acute myeloid leukemia develop resistance to standard therapies.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

First-in-Human Cancer Drug Trial at Ohio State

In August 2025, researchers at the OSUCCC – James launched a groundbreaking first-in-human clinical trial for a novel cancer drug developed internally to treat patients with limited therapeutic options.

OncoDaily

OhioHealth Bradley Cancer Center Expansion

OhioHealth announced a $10.2 million investment in August 2026 to expand the Bradley Cancer Center at Berger Hospital, which will increase infusion capacity and diagnostic capabilities over the next two years.

Becker's Oncology

Dietary Impact Research Grants

Researchers at the OSUCCC – James were awarded nearly $4 million in grants in September 2026 to study how tailored nutritional plans influence biological processes associated with breast and colorectal cancer risk.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

This section is refreshed on a recurring schedule. Entries are AI-assisted research signals organized from public oncology sources and should be verified against the original sources. Information is educational and does not constitute medical advice.

Huippu Prodigy Platforms

© 2026 Huippu Prodigy Platforms, LLC.

CS Cancer Solutions is operated by Huippu Prodigy Platforms, LLC.

Public-Source Oncology Research • Educational and Research Use

Structured Oncology Research Intelligence